Lipoprotein(a), apolipoprotein(a) polymorphism, and insulin treatment in type II diabetic patients

Diabetes Care. 1995 Aug;18(8):1202-3. doi: 10.2337/diacare.18.8.1202.
No abstract available

Publication types

  • Comparative Study
  • Letter

MeSH terms

  • Administration, Oral
  • Apolipoproteins / blood*
  • Apolipoproteins / genetics
  • Apoprotein(a)
  • Blood Glucose / metabolism
  • Blood Pressure
  • Cholesterol / blood
  • Diabetes Mellitus, Type 2 / blood*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetic Angiopathies / blood
  • Female
  • Fructosamine
  • Glycated Hemoglobin / analysis
  • Hexosamines / blood
  • Humans
  • Hypertension / blood
  • Hypoglycemic Agents / administration & dosage
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use*
  • Lipoprotein(a) / blood*
  • Lipoprotein(a) / genetics
  • Male
  • Middle Aged
  • Molecular Weight
  • Polymorphism, Genetic*
  • Triglycerides / blood

Substances

  • Apolipoproteins
  • Blood Glucose
  • Glycated Hemoglobin A
  • Hexosamines
  • Hypoglycemic Agents
  • Insulin
  • Lipoprotein(a)
  • Triglycerides
  • Fructosamine
  • Cholesterol
  • Apoprotein(a)